Leadership Team

CHIEF EXECUTIVE OFFICE OF ABL GROUP

Thierry serves as and as a member of the Board of Directors. Thierry was appointed CEO in October 2021

CHIEF FINANCIAL OFFICER

A financial leader with exceptional analytical, communication, and interpersonal skills. Progressive background includes over twenty years of business experience with exposure to many functional areas in…

VICE PRESIDENT, INNOVATION AND TRANSLATION

The Innovation and Translation team manages ABL’s portfolio of government contracts that drive the transformation of ideas to novel clinical products that prevent and treat infectious disease. The services the Innovation team provides include early discovery of suitable…

VICE PRESIDENT, IMMUNOLOGY

Dr. Lemiale has over 25 years of experience in immunology, applied to vaccine research and development. His scientific focus has been on preclinical development of vaccine candidates and on the development and…

VICE PRESIDENT, QUALITY OPERATIONS

N-Neka Smith joined ABL in June 2021. She serves as the Vice President of Quality Operations, which includes direct oversite of Quality Assurance, Quality Control, and Analytical Development. N-Neka is a dynamic Quality Leader with versatile expertise in Clinical and Commercial Contract Manufacturing.

DIRECTEUR GÉNÉRAL, ABL EUROPE

Dr. Mahieux joined ABL in January 2016 as ABL Europe General Manager. He has a strong experience in vaccine GMP manufacturing. He began his professional career with Pasteur Mérieux in 1993 and held…

DIRECTOR OF HUMAN RESOURCES

Yulia, Director of Human Resources, comes to ABL, Inc. with diverse experiences in Human Resources, leading training & development, employee engagement, talent acquisition, workforce planning, performance coaching, and organizational change management to enable the growth of organizational capabilities and infrastructure.